Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder

INTRODUCTION: Previous study has identified increased antithrombin III (ATIII) in patients with major depressive disorder (MDD), supporting ATIII as a potential biomarker for depression diagnosis. OBJECTIVES: This study aimed to reveal the alteration of ATIII after occipital repetitive transcranial...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, R., Shi, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470394/
http://dx.doi.org/10.1192/j.eurpsy.2021.310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470394/
http://dx.doi.org/10.1192/j.eurpsy.2021.310

Ejemplares similares